cagrilintide retatrutide combination trial We are all anxiously awaiting more research on the of and semaglutide (#ozempic/#wegovy) which has been shown in global studies to induce very meaningful #weightloss. This study assessed the efficacy Cagrilintide is a long-acting amylin

Warfarin requires careful monitoring and dose adjustment with regular INR testing, while DOACs (e.g., apixaban, rivaroxaban) do not require routine coagulation monitoring

A meta-analysis of 113 RCTs comprising 33,167 patients in the GLP-1 RA cohort and 26,683 in the comparator cohort revealed no significant elevation in pancreatitis or pancreatic cancer risk relative to control groups (Mantel-Haenszel odds ratio [MH-OR] of 0.93 and 0.94, respectively), but identified a notable increase in cholelithiasis risk (MH-OR, 1.30) [58]

GLP-1 naturally occurs in the body to regulate insulin production but degrades very quickly in the bloodstream

These studies will let us know more about how safe it is and how well it works when we compare it to other drugs

But if you stop taking it long-term, theres a pretty high chance of weight regain, Dr

Both emerged from pipelines designed to push metabolic therapy beyond what semaglutide and tirzepatide could achieve alone